Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 4/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.55 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.50 |
| ▸ | GSR | P00390 | 2/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.50 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.50 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | GRM8 | O00222 | 1/20 | 0.50 |
| ▸ | GRM6 | O15303 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 1/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.50 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.50 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL6929758 | 1.00 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11SLC1A3SLC1A2 | |
| Serine SCHEMBL4455818 | 1.00 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11SLC1A3SLC1A2 | |
| Serine SCHEMBL2023739 | 1.00 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11SLC1A3SLC1A2 | |
| Serine SCHEMBL6520912 | 1.00 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11SLC1A3SLC1A2 | |
| (D)-Serine SCHEMBL6038168 | 1.00 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11SLC1A3SLC1A2 | |
| Serine SCHEMBL2023740 | 1.00 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11SLC1A3SLC1A2 | |
| (D)-Serine SCHEMBL43094 | 1.00 | — | — | |
| Serine SCHEMBL1332181 | 1.00 | — | — | |
| (D)-Serine SCHEMBL6660617 | 1.00 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11SLC1A3SLC1A2 | |
| Serine SCHEMBL6520918 | 1.00 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0863762-A4 | METHODS OF PRODUCTION AND USE OF LIQUID FORMULATIONS OF PLASMA PROTEINS | AMERICAN NAT RED CROSS (US) | 2003-04-23 | — | — | EP | disclosed |
| US-5925738-A | STABLE AQUEOUS LIQUID OF PLASMA PROTEIN, BUFFER, CALCIUM IONS, AND OSMOTIC MODULATING AGENT; FOR TREATMENT OF BLOOD DISORDERS BY ADMINISTRATION OF BLOOD COAGULATION FACTORS | THE AMERICAN NATIONAL RED CROSS (US) | 1999-07-20 | — | — | US | disclosed |
| EP-0863762-A1 | METHODS OF PRODUCTION AND USE OF LIQUID FORMULATIONS OF PLASMA PROTEINS | The American National Red Cross (US) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997019687-A9 | METHODS OF PRODUCTION AND USE OF LIQUID FORMULATIONS OF PLASMA PROTEINS | — | 1997-09-25 | — | — | WO | disclosed |
| WO-1997019687-A1 | METHODS OF PRODUCTION AND USE OF LIQUID FORMULATIONS OF PLASMA PROTEINS | THE AMERICAN NATIONAL RED CROSS (US) | 1997-06-05 | — | — | WO | disclosed |